Malignant hyperthermia following preoperative oral administration of dantrolene.
D000759:Adjuvants, Anesthesia / Q000009:adverse effects; D000777:Anesthetics / Q000009:adverse effects*; D002648:Child; D003402:Creatine Kinase / Q000097:blood; D003620:Dantrolene / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008305:Malignant Hyperthermia / Q000139:chemically induced* / Q000517:prevention & control
D000759:Adjuvants, Anesthesia; D000777:Anesthetics; D003402:Creatine Kinase; D003620:Dantrolene